Substance Use Within Trials of Psychological Interventions for Psychosis: Sample Inclusion, Secondary Measures, and Intervention Effectiveness
- PMID: 38777384
- PMCID: PMC11548936
- DOI: 10.1093/schbul/sbae073
Substance Use Within Trials of Psychological Interventions for Psychosis: Sample Inclusion, Secondary Measures, and Intervention Effectiveness
Abstract
Introduction: Current clinical guidelines recommend that patients with co-occurring psychosis and alcohol or substance use disorders (A/SUD) receive evidenced-based treatment for both disorders, including psychological intervention for psychosis. However, the efficacy of such treatments for individuals with co-occurring psychosis and A/SUD is unclear.
Study design: Randomized controlled trials (RCTs) of psychological interventions for psychosis were systematically reviewed, to investigate how alcohol and substance use has been accounted for across sample inclusion and secondary measures. Findings from trials including individuals with co-occurring alcohol or substance use issues were then narratively summarized using the Synthesis Without Meta-Analysis guidelines, to indicate the overall efficacy of psychological interventions for psychosis, for this comorbid population.
Study results: Across the 131 trials identified, 60.3% of trials excluded individuals with alcohol or substance use issues. Additionally, only 6.1% measured alcohol or substance use at baseline, while only 2.3% measured alcohol or substance use as a secondary outcome. Across trials explicitly including individuals with alcohol or substance use issues, insufficient evidence was available to conclude the efficacy of any individual psychological intervention. However, preliminary findings suggest that psychoeducation (PE) and metacognitive therapy (MCT) may be proposed for further investigation.
Conclusion: Overall, co-occurring alcohol and substance use issues have been largely neglected across the recent RCTs of psychological interventions for psychosis; highlighting the challenges of making treatment decisions for these individuals using the current evidence base.
Keywords: alcohol; comorbidity; psychological interventions; psychosis; substance.
© The Author(s) 2024. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center.
Similar articles
-
Psychological interventions for co-occurring depression and substance use disorders.Cochrane Database Syst Rev. 2019 Nov 26;2019(11):CD009501. doi: 10.1002/14651858.CD009501.pub2. Cochrane Database Syst Rev. 2019. PMID: 31769015 Free PMC article.
-
No Wrong Doors: Findings from a Critical Review of Behavioral Randomized Clinical Trials for Individuals with Co-Occurring Alcohol/Drug Problems and Posttraumatic Stress Disorder.Alcohol Clin Exp Res. 2017 Apr;41(4):681-702. doi: 10.1111/acer.13325. Epub 2017 Feb 10. Alcohol Clin Exp Res. 2017. PMID: 28055143 Review.
-
[Epidemiology, etiology and treatment of patients with psychosis and co-morbid substance use disorder].Ther Umsch. 2018 Jun;75(1):37-43. doi: 10.1024/0040-5930/a000964. Ther Umsch. 2018. PMID: 29909760 Review. German.
-
Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.Med J Aust. 2019 Nov;211 Suppl 9:S3-S46. doi: 10.5694/mja2.50383. Med J Aust. 2019. PMID: 31679171
-
A systematic review and meta-analysis of psychosocial interventions for persons with comorbid anxiety and substance use disorders.J Subst Use Addict Treat. 2024 Oct;165:209442. doi: 10.1016/j.josat.2024.209442. Epub 2024 Jun 16. J Subst Use Addict Treat. 2024. PMID: 38889880
References
-
- Brunette MF, Mueser KT, Babbin S, et al.Demographic and clinical correlates of substance use disorders in first episode psychosis. Schizophr Res. 2018;194:4–12. - PubMed
-
- Hunt GE, Large MM, Cleary M, Lai HMX, Saunders JB.. Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990–2017: systematic review and meta-analysis. Drug Alcohol Depend. 2018;191:234–258. - PubMed
-
- Sara GE, Burgess PM, Malhi GS, Whiteford HA, Hall WC.. Stimulant and other substance use disorders in schizophrenia: prevalence, correlates and impacts in a population sample. Aust N Z J Psychiatry. 2014;48:1036–1047. - PubMed
-
- Dixon L. Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophr Res. 1999;35:S93–S100. - PubMed